<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T13:23:01.849888"><meta name="build-number" content="${buildNumber}">       <title>华尔街分析师：减肥药是泡沫、诺和诺德估值太高了！但短期无法阻挡 | 2023-10-19</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="华尔街分析师：减肥药是泡沫、诺和诺德估值太高了！但短期无法阻挡 | 2023-10-19"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="2023-10-19 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="10851.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="华尔街分析师：减肥药是泡沫、诺和诺德估值太高了！但短期无法阻挡 | 2023-10-19"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "10851.html#webpage", "url": "10851.html", "name": "华尔街分析师：减肥药是泡沫、诺和诺德估值太高了！但短期无法阻挡 | 2023-10-19", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "2023-10-19 Help" }</script><!-- End Schema.org --></head>      <body data-id="10851" data-main-title="华尔街分析师：减肥药是泡沫、诺和诺德估值太高了！但短期无法阻挡" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>2023-10-19  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="10851"   id="10851.md">华尔街分析师：减肥药是泡沫、诺和诺德估值太高了！但短期无法阻挡</h1>  <p id="4dc3211_10"><span class="control" id="4dc3211_11">华尔街见闻</span></p><p id="4dc3211_12"><span class="control" id="4dc3211_13">2023-10-19 08:40</span></p><p id="4dc3211_14"><span class="control" id="4dc3211_15">https://news.futunn.com/post/33022337</span></p><p id="4dc3211_16">一些分析师更加悲观，杰富瑞和法兴银行的分析师都认为，诺和诺德有可能下跌约40%。</p><p id="4dc3211_17">减肥药，还能火多久？</p><p id="4dc3211_18">开普勒盛富证券（Kepler Cheuvreux）的一位分析师表示，股市对减肥药的狂热正在制造一个泡沫。彭博社追踪的一些分析师更加悲观，杰富瑞(Jefferies)和法兴银行(Societe Generale)的分析师都认为，诺和诺德有可能下跌约40%。</p><p id="4dc3211_19">受Wegovy等&ldquo;减肥神药&rdquo;热销的推动，Ozempic生产商诺和诺德的股价今年已经上涨了近50%。然而，开普勒盛富证券的David Evans表示，目前的估值已经&ldquo;非常高&rdquo;。</p><figure  id="4dc3211_20"><img alt="16977010641737316864351" src="https://postimg.futunn.com/16977010641737316864351.png" title="16977010641737316864351"   ></figure><p id="4dc3211_21">不过Evans认为短期内没有什么因素可以阻挡诺和诺德股价的飙升，并重申了他对诺和诺德的持有评级，其在最新的一份报告中写道：</p><aside class="prompt" data-type="tip" data-title="" id="4dc3211_22"><p id="4dc3211_23">&ldquo;我们认为减肥药爆火是一个泡沫，但什么会戳破它？我们认为短期内没有任何驱动因素。&rdquo;</p></aside><p id="4dc3211_24">Evans的观点对诺和诺德的股价提出了警告。上个月，诺和诺德超越奢侈品巨头路威酩轩(LVMH)，成为欧洲市值最高的上市公司。高盛分析师本周预测，到2030年，减肥药的市场规模将达到1000亿美元。</p><p id="4dc3211_25">自8月份以来，诺和诺德股价大幅上涨，当时一项研究发现Wegovy降低了心脏病发作和中风的风险。而如今的股价表明，人们普遍认为，该药物的最高销售额需要再翻一番，达到250亿美元以上，才能证明股价走势的合理性。</p><p id="4dc3211_26">根据彭博汇编的数据，诺和诺德的预期市盈率约为34倍，是欧洲斯托克600医疗保健指数成分股平均市盈率的两倍。</p><p id="4dc3211_27">Evans表示：</p><aside class="prompt" data-type="tip" data-title="" id="4dc3211_28"><p id="4dc3211_29">&ldquo;可能是由于其独特的吸引力，与历史平均水平和同行相比，诺和诺德的估值已经变得非常高，天价估值需要更大的盈利增长。&rdquo;</p></aside><p id="4dc3211_30">编辑/ruby</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="10852.html">港市速睇 | 港股再度下行，科指跌近2%，京东跌超5%；手机设备股逆市走强，舜宇光学涨近9%</a>   <a class="navigation-links__next" href="10850.html">华尔街热议的美债&ldquo;期现溢价&rdquo;，到底是什么？</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>